BD, McKesson Corporation and KUKA AG are Dominating the Europe Pharmacy Automation Market in 2019

Europe Pharmacy Automation Market is expected to grow with the CAGR of 7.39% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/europe-pharmacy-automation-market

Europe pharmacy automation market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in Europe pharmacy automation market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement into the market. This has helped the companies to maximize the sales with enhanced product portfolio. For instance, in December 2019, Grifols, S.A. introduced KIRO Fill. This KIRO Fill brings greater autonomy to syringe batching of non-hazardous intravenous (IV) medications. KIRO Fill was aimed to improve the patient safety, boost operational efficiencies, and simplify regulatory compliance. This has enabled the company to enhance their product portfolio and to grow in the market.

BD is the dominating player in Europe pharmacy automation market. The other key players existing in the market includes OMNICELL, INC., Cerner Corporation, Capsa Healthcare, Baxter, McKesson Corporation, AmerisourceBergen Corporation, vitabook GmbH, TOSHO co., Inc., Gebr. Willach GmbH, Global Healthcare Exchange, LLC., BIQHS, Grifols, S.A., Synergy Medical, APD Algoritmos Procesos y Diseños S.A, JVM Europe BV, Mediwell Systems Ltd., Genesis Automation LTD, PHARMAGEST INTERACTIVE, FarmaTools, Deenova S.r.l., MEKAPHARM, KUKA AG, Rohmann-Automation GmbH, KLS Pharma Robotics GmbH and Med Management among others.

Europe Pharmacy Automation MarketBD

BD is headquartered in New Jersey, U.S. and was incorporated in 1897. The company is engaged in the development, manufacturing and sale of a wide range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company has multiple business segments such as medical, life sciences and interventional, in which medical is the market focused segment. The company is providing products under anesthesia delivery, biosciences, biosurgery, cervical cancer screening, diabetes care, drug delivery systems, gastrointestinal care, hazardous drug safety, hernia repair and fixation, home care, infection prevention, infusion therapy, interventional specialties, lab automation, medication and supply management, microbiology solutions, molecular diagnostics, patient monitoring and temperature management, prostate health, respiratory care, sharps disposal solutions, software solutions, specimen collection, surgical instruments, syringes and needles, urology and kidney health, vascular access, vascular surgery, wound care. The market focus products lie under medication and supply management product category. The company is engaged in continuous development of pharmacy automation.

  • In December 2014, BD’s acquired company CareFusion launched its new innovations in order to expand its capabilities of its enterprise-wide medication management solutions for usage in the hospitals and outpatient settings. The new product launched includes Pyxis Mini system. This new innovation launched by the company has strengthened its pharmacy automation systems portfolio.

The company has wide presence across Europe, North America, South America, Asia-Pacific and Middle East and Africa. The company also has various subsidiary companies such as Accuri Cytometers, Inc.(Delaware), Accuri Cytometers (Europe), Ltd. (U.K.), Atto Bioscience, Inc. (Delaware) and B-D (Cambridge U.K.) Ltd. (U.K.), among others.

McKesson Corporation

McKesson Corporation was founded in 1833 and is headquartered in Texas, U.S. The company focuses on providing healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. The company offers business segments such as U.S. pharmaceutical and specialty solutions, European pharmaceutical solutions, medical-surgical solutions and other among which U.S. pharmaceutical and specialty solutions and European pharmaceutical solutions are the market focussed category. The company is engaged in providing products in categories such as pharmaceutical distribution, wholesale medical supplies, pharmacy services & technology, solutions for specialty practices and solutions for biopharma among which pharmaceutical distribution, pharmacy services & technology and solutions for specialty practices are the market focused categories.

  • In February 2018, McKesson Corporation collaborated with Creative Pharmacist, a U.S. based pharmacist launch clinical service in order to enhance the clinical programme for community pharmacies. This collaboration has strengthened the pharmacy management systems of the company leading to its increased demand in the market.

The company has wide presence across Europe and North America. The company has various subsidiary companies such as ClarusONE Sourcing Services LLP (U.K.), McKesson Europe AG (Germany), McKesson Medical-Surgical Inc. (U.S.), McKesson Strategic Services Limited (U.S.) and US Oncology Holdings, Inc. (U.S.), among more. The company has initiated many strategic initiatives to expand its market.

KUKA AG

KUKA AG is headquartered in Augsburg, Germany and was incorporated in 1898. The company is engaged in the development of intelligent automation solutions from robots and cells to fully automated systems with networking in markets such as automotive, electronics, general industry, consumer goods, e-commerce/retail and healthcare. The company has multiple business segments such as systems, robotics, swisslog, swisslog healthcare, china, in which systems, robotics, swisslog, swisslog healthcare is the market focused segment. The company is providing products under robot systems, production machines, production systems, automated guided vehicle systems, mobility, and process technologies. The market focus products lie under robot systems product category. The company is engaged in continuous development of pharmacy automation.

  • In September 2020, KUKA AG has partnered with SEOJIN Industrial to deliver 185 robots to the SEOJIN industrial. The company is going to release its 185 KUKA robots of KR QUANTEC series. The company would enhance its productivity along with the revenue generation that is going to enhance the sales of the company.

The company has wide presence across Europe, North America, South America, Asia-Pacific and Middle East and Africa. The company also has various subsidiary companies such as KUKA Systems (Germany), Swisslog (Switzerland), Reis Robotics (Germany), KUKA Systems Corporation North America (U.S.) and KUKA Iberia S.A. (Argentina) among others.